Higher-dose triple agonist delivering enhanced weight reduction (up to ~24%+ in studies),
greater fat burning/energy expenditure, superior metabolic/glycemic benefits, dramatic liver fat
decreases (80-86%+ reductions, normalization in 85-93% on high doses in NAFLD), potential
lean mass preservation, and improved cardiometabolic/liver health markers.
$135.00
